Zheng Y - Search Results

1

A strategy for the improvement of the bioavailability and antiosteoporosis activity of BCS IV flavonoid glycosides through the formulation of their lipophilic aglycone into nanocrystals.

Li Y, Sun S, Chang Q, Zhang L, Wang G, Chen W, Miao X, Zheng Y. Li Y, et al. Among authors: zheng y. Mol Pharm. 2013 Jul 1;10(7):2534-42. doi: 10.1021/mp300688t. Epub 2013 May 24. Mol Pharm. 2013. PMID: 23659498

2

Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid.

Xi J, Chang Q, Chan CK, Meng ZY, Wang GN, Sun JB, Wang YT, Tong HH, Zheng Y. Xi J, et al. Among authors: zheng y. AAPS PharmSciTech. 2009;10(1):172-82. doi: 10.1208/s12249-009-9190-9. Epub 2009 Feb 18. AAPS PharmSciTech. 2009. PMID: 19224372 Free PMC article.

3

Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: formulation and bioavailability studies.

Zhao Y, Wang C, Chow AH, Ren K, Gong T, Zhang Z, Zheng Y. Zhao Y, et al. Among authors: zheng y. Int J Pharm. 2010 Jan 4;383(1-2):170-7. doi: 10.1016/j.ijpharm.2009.08.035. Epub 2009 Sep 2. Int J Pharm. 2010. PMID: 19732813

4

Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound.

Tong HH, Du Z, Wang GN, Chan HM, Chang Q, Lai LC, Chow AH, Zheng Y. Tong HH, et al. Among authors: zheng y. Int J Pharm. 2011 Feb 14;404(1-2):148-58. doi: 10.1016/j.ijpharm.2010.11.027. Epub 2010 Nov 19. Int J Pharm. 2011. PMID: 21094233

5

Oral absorption and excretion of icaritin, an aglycone and also active metabolite of prenylflavonoids from the Chinese medicine Herba Epimedii in rats.

Chang Q, Wang GN, Li Y, Zhang L, You C, Zheng Y. Chang Q, et al. Among authors: zheng y. Phytomedicine. 2012 Aug 15;19(11):1024-8. doi: 10.1016/j.phymed.2012.05.017. Epub 2012 Jul 2. Phytomedicine. 2012. PMID: 22762938

6

[Simultaneous determination and optimization of extraction process of catalpol and acteoside from rehmanniae radix].

Huang LT, Sun SP, Zheng Y. Huang LT, et al. Among authors: zheng y. Zhong Yao Cai. 2012 Aug;35(8):1318-22. Zhong Yao Cai. 2012. PMID: 23320366 Chinese.

7

Effects of nanosuspension formulations on transport, pharmacokinetics, in vivo targeting and efficacy for poorly water-soluble drugs.

Wang Y, Miao X, Sun L, Song J, Bi C, Yang X, Zheng Y. Wang Y, et al. Among authors: zheng y. Curr Pharm Des. 2014;20(3):454-73. doi: 10.2174/13816128113199990403. Curr Pharm Des. 2014. PMID: 23651402 Review.

8

Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.

Sun J, Bi C, Chan HM, Sun S, Zhang Q, Zheng Y. Sun J, et al. Among authors: zheng y. Colloids Surf B Biointerfaces. 2013 Nov 1;111:367-75. doi: 10.1016/j.colsurfb.2013.06.032. Epub 2013 Jun 25. Colloids Surf B Biointerfaces. 2013. PMID: 23856543

9

Nanosuspension development of scutellarein as an active and rapid orally absorbed precursor of its BCS class IV glycoside scutellarin.

Yang X, Miao X, Cao F, Li S, Ai N, Chang Q, Lee SMY, Zheng Y. Yang X, et al. Among authors: zheng y. J Pharm Sci. 2014 Nov;103(11):3576-3584. doi: 10.1002/jps.24149. Epub 2014 Sep 3. J Pharm Sci. 2014. PMID: 25187229

10

Chinese Medicine in Inhalation Therapy: A Review of Clinical Application and Formulation Development.

Miao X, Zhou J, Li J, Liao Y, Zheng Y. Miao X, et al. Among authors: zheng y. Curr Pharm Des. 2015;21(27):3917-31. doi: 10.2174/1381612821666150820110550. Curr Pharm Des. 2015. PMID: 26290197 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,391 results

Search Page

Filters